Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-28T09:01:24.004Z Has data issue: false hasContentIssue false

Chapter 2 - Monitoring of Ovarian Stimulation

Published online by Cambridge University Press:  09 November 2022

By
Lewis Nancarrow  and
Andrew Drakeley
Edited by
Rachel Cutting  and
Mostafa Metwally
Rachel Cutting
Affiliation:
Human Fertilisation and Embryology Authority, London
Mostafa Metwally
Affiliation:
Sheffield Teaching Hospitals and the University of Sheffield
Get access

Summary

Monitoring of ovarian stimulation plays a key role in the recruitment of mature oocytes, which in turn leads to better fertilisation rates and embryo development.

Type
Chapter
Information
Manual of Oocyte Retrieval and Preparation in Human Assisted Reproduction , pp. 10 - 17
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hardiman, P, Thomas, M, Osgood, V, Vlassopoulou, V, Ginsburg, J. (1990) Are estrogen assays essential for monitoring gonadotropin stimulant therapy? Gynecol Endocrinol 4(4):261–9. doi: 10.3109/09513599009024980CrossRefGoogle ScholarPubMed
Patil, M. Monitoring ovarian stimulation: current perspectives. In: Allahbadia, GN, Morimoto, Y, eds. Ovarian Stimulation Protocols. New Delhi: Springer, 2016; 17–55.Google Scholar
Salama, S., Torre, A, Paillusson, B, et al. Ovarian stimulation monitoring: past, present and perspectives. Gynecol Obstet Fertil 2011;39(4):245–54. doi: 10.1016/j.gyobfe.2011.02.003Google Scholar
Ryan, A, Wang, S, Alvero, R, Polotsky, AJ. Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome. J Assist Reprod Genet 2014;31(7):837–42. doi: 10.1007/s10815-014-0253-9Google Scholar
Kwan, I, Bhattacharya, S, Kang, A, Woolner, A. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). Cochrane Database Syst Rev 2014;8:CD005289. doi: 10.1002/14651858.CD005289.pub3Google Scholar
Lawrenz, B, Labarta, E, Fatemi, H, Bosch, E. Premature progesterone elevation: targets and rescue strategies. Fertil Steril 2018;109(4) :577–82. doi: 10.1016/j.fertnstert.2018.02.128CrossRefGoogle ScholarPubMed
Abbara, A, Vuong, LN, Ho, VNA, et al. Follicle size on day of trigger most likely to yield a mature oocyte. Front Endocrinol (Lausanne) 2018;9:193. doi:10.3389/fendo.2018.00193CrossRefGoogle ScholarPubMed
Hu, X, Luo, Y, Huang, K, et al. New perspectives on criteria for the determination of HCG trigger timing in GnRH antagonist cycles. Medicine (Baltimore) 2016;95(20):e3691. doi: 10.1097/MD.0000000000003691Google Scholar
Wang, W, Zhang, XH, Wang, WH, et al. The time interval between hCG priming and oocyte retrieval in ART program: a meta-analysis. J Assist Reprod Genet 2011;28(10):901–10. doi: 10.1007/s10815-011-9613-xCrossRefGoogle ScholarPubMed
Andersen, AG, Als-Nielsen, B, Hornnes, PJ, Franch Andersen, L. Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture. Hum Reprod 1995;10(12):3202–5. doi: 10.1093/oxfordjournals.humrep.a135888CrossRefGoogle ScholarPubMed
European Recombinant LH Study Group. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 2001;86(6):2607–18. doi: 10.1210/jcem.86.6.7599Google Scholar
Youssef, MA, Abou-Setta, AM, Lam, WS. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database Syst Rev 2016;4:CD003719. doi: 10.1002/14651858.CD003719.pub4Google Scholar
Abdalla, HI, Ah-Moye, M, Brinsden, P, et al. The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program. Fertil Steril 1987;48(6):958–63. doi: 10.1016/s0015-0282(16)59591-0CrossRefGoogle Scholar
Abbara, A, Clarke, SA, Dhillo, WS. Novel concepts for inducing final oocyte maturation in in vitro fertilization treatment. Endocr Rev 2018;39(5):593628. doi: 10.1210/er.2017-00236Google Scholar
Hoyos, LR, Khan, S, Dai, J, et al. Low-dose urinary human chorionic gonadotropin is effective for oocyte maturation in in vitro fertilization/intracytoplasmic sperm injection cycles independent of body mass index. Int J Fertil Steril 2016;11(1):7–14. doi: 10.22074/ijfs.2016.5145Google Scholar
Youssef, MAFM, van der Veen, F, Al‐Inany, HG, et al. Gonadotropin‐releasing hormone agonist versus HCG for oocyte triggering in antagonist‐assisted reproductive technology. Cochrane Database Syst Rev 2014;10:CD008046. doi: 10.1002/14651858.CD008046.pub4Google Scholar
Engmann, LL, Maslow, BS, Kaye, LA, et al. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome – a prospective randomized double-blind clinical trial. J Ovarian Res 2019;12(1):8. doi: 10.1186/s13048-019-0483-7Google Scholar
Jayasena, CN, Abbara, A, Comninos, AN, et al. Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest 2014;124(8): 3667–77. doi: 10.1172/JCI75730Google Scholar
Govaerts, I, Devreker, F, Delbaere, A, Revelard, P, Englert, Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol 1998;77(2):239–43. doi: 10.1016/s0301-2115(97)00263-7.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×